Affiliation:
1. Department of Biotechnology, Government College for Men, Kadapa –516 004, A.P,India
2. Department of Zoology, Yogi Vemana University, Kadapa – 516 005, A.P,India
Abstract
:
Recently, novel coronavirus infection (COVID-19) emerged in Wuhan, China has been
declared as pandemic by WHO. Until now, no evidence is documented regarding its wild animal
reservoir or intermediary host, but, human-to-human transmission, asymptomatic carriers were
very much observed. The number of confirmed cases and death toll have been increased almost all
over the world indicating its potential threat to public health. Though the phylogenetic analysis
shows some similarity of SARS-CoV2 to bat betacoronaviruses, it exhibited significant variation in
S1 domain of spike protein from bat-derived viruses. S1 domain plays an important role in receptor
binding and it can be a target for the development of therapeutics and vaccines. In this review, we
have discussed the updates on transmission, diagnosis, genome analysis and comparison, treatment
options and clinical trials of COVID-19.
Funder
Science & Engineering Research Board
Publisher
Bentham Science Publishers Ltd.
Subject
Microbiology (medical),Pharmacology,Molecular Medicine,General Medicine
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献